133 related articles for article (PubMed ID: 11518790)
1. Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
Glicklich D; Burris L; Urban A; Tellis V; Greenstein S; Schechner R; Devarajan P; Croizat H
J Am Soc Nephrol; 2001 Sep; 12(9):1958-1964. PubMed ID: 11518790
[TBL] [Abstract][Full Text] [Related]
2. Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis.
Glicklich D; Kapoian T; Mian H; Gilman J; Tellis V; Croizat H
Transplantation; 1999 Jul; 68(1):62-6. PubMed ID: 10428268
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition induces death receptor apoptotic pathways in erythroid precursors following renal transplantation.
Glezerman I; Patel H; Glicklich D; Croizat H; Devarajan P
Am J Nephrol; 2003; 23(4):195-201. PubMed ID: 12748417
[TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
[TBL] [Abstract][Full Text] [Related]
5. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines.
Morrone LF; Di Paolo S; Logoluso F; Schena A; Stallone G; Giorgino F; Schena FP
Transplantation; 1997 Sep; 64(6):913-8. PubMed ID: 9326420
[TBL] [Abstract][Full Text] [Related]
6. Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis.
Gupta M; Miller BA; Ahsan N; Ulsh PJ; Zhang MY; Cheung JY; Yang HC
Transplantation; 2000 Oct; 70(8):1188-94. PubMed ID: 11063339
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.
Vishnu P; Moreno Vanegas Y; Wadei HM; Rivera CE
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954763
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
Trivedi H; Lal SM
Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
[TBL] [Abstract][Full Text] [Related]
10. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
Minerva Urol Nefrol; 2002 Sep; 54(3):189-92. PubMed ID: 12384621
[TBL] [Abstract][Full Text] [Related]
12. Association of post-renal transplant erythrocytosis and microalbuminuria: response to angiotensin-converting enzyme inhibition.
Mulhern JG; Lipkowitz GS; Braden GL; Madden RL; O'Shea MH; Harvilchuck H; Guarnera JM; Germain MJ
Am J Nephrol; 1995; 15(4):318-22. PubMed ID: 7573190
[TBL] [Abstract][Full Text] [Related]
13. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
[TBL] [Abstract][Full Text] [Related]
15. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
Minerva Urol Nefrol; 2002 Jun; 54(2):145-8. PubMed ID: 12070465
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline].
D'Amelio A; Bonucchi D; Patruno P; Ballestri M; Mastrangelo F
Minerva Cardioangiol; 1997 Nov; 45(11):567-72. PubMed ID: 9549290
[TBL] [Abstract][Full Text] [Related]
18. Studies of erythroid burst-forming units in patients with posttransplant erythrocytosis.
Glicklich D; Kapoian T; Mian H; Greenstein S; Tellis V; Croizat H
Transplant Proc; 1999; 31(1-2):1284-5. PubMed ID: 10083573
[No Abstract] [Full Text] [Related]
19. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
[No Abstract] [Full Text] [Related]
20. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients.
Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K
Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
